openPR Logo
Press release

Learns Details of the Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market

09-06-2017 03:27 PM CET | Health & Medicine

Press release from: Transparency Market Research

Learns Details of the Chronic Inflammatory Demyelinating

Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow of electrical impulses through the nerve fibers. In patients suffering from CIPD the immune system damages or destroys the myelin due to which the nerve fibers become weak, this leads to loss or weakening of the electrical impulses in the arms and legs and cause weakness or loss of sensation.

Obtain Report Details @ http://www.transparencymarketresearch.com/chronic-inflammatory-demyelinating-polyneuropathy-treatment-market.html

CIPD can occur at any age and in both genders. However the frequency of incidence is high among men as compared to women. The rate of recovery of the patient depends on the early diagnosis of the disease. Most CIPD patients respond well to the therapy if it is provided at the early stage of onset of the disorder so that the damage to the peripheral nerves can be controlled which contributes to the improved function and better quality of life for the patient.

With increasing number of new cases of CIDP and absence of permanent treatment is increasing the prevalence rate of CIPD globally. According to the American Association of Neuromuscular & Electrodiagnostic Medicine approximately 40,000 patients in the U.S. are affected by CIPD at any one time in time. The growing prevalence rate is expected to boost demand for CIPD treatment over the forecast period. Growing research in the field of CIPD treatment is expected to deliver new drugs which in turn is expected to increase the demand for CIPD treatment drugs over the forecast period. As per the clinicaltrials. gov currently there are 38 ongoing clinical trials for CIPD treatment.

Organizations like GBS/CIPD Foundation International are focusing on creating awareness about CIPD and similar disorders by providing support to the patients and their families and caregivers and are focusing on development of national and international support groups. Awareness and support initiatives are expected to propel revenue growth. However the awareness initiatives are gaining traction in developed economies the awareness of CIPD and related treatments remain low in emerging low income economies.

The CIPD treatment market is segmented by treatment type and by geography. By treatment type the global CIPD treatment market is segmented into corticosteroids, intravenous immunoglobulin and plasmapheresis (plasma exchange). Along with the primary treatment methods physicians also opt for of the treatments like chemotherapy, physiotherapy for strengthening the muscles. The secondary treatments are mainly preferred when primary treatments fail or exhibit side effects on the patient’s health.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=16256

By geography the global CIPD treatment market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific (APAC) and Middle East and Africa (MEA). North America and Europe are expected to dominate the CIPD treatment market over the forecast period. Increasing research and awareness programs are expected to promote revenue growth of CIPD treatment market in these regions. Asia Pacific CIPD treatment market is expected to witness high growth owing to high population which in turn is expected to increase the prevalence rate of CIPD in this region. Latin America and MEA are expected to follow up with the other regions owing to growing awareness, growing healthcare infrastructure and increasing per capita healthcare spending.

Some key participants in the CIPD treatment market are Baxter International Inc., Kedrion S.p.A, Octapharma AG, CSL Behring, Grifols, S.A. and others.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Learns Details of the Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market here

News-ID: 701166 • Views: 252

More Releases from Transparency Market Research

Electromechanical Microwave Switch Market To receive overwhelming hike in Revenu …
Transparency Market Research delivers key insights on the global electromechanical microwave switch market. Get Report Details- https://www.transparencymarketresearch.com/electromechanical-microwave-switch-market.html In terms of revenue, the global electromechanical microwave switch market is estimated to expand at a CAGR of ~5% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global electromechanical microwave switch market. Grab an Exclusive PDF Sample of this Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82213 Electromechanical Microwave
Emerging trends of the High Reliability Semiconductor Market 2021-2031
Transparency Market Research delivers key insights on the global high reliability semiconductor market. In terms of revenue, the global high reliability semiconductor market is extended to expand at a CAGR of ~5% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the global high reliability semiconductor market. Get Report Details- https://www.transparencymarketresearch.com/high-reliability-semiconductors-market.html The global high reliability semiconductor market is broadly affected by
DUV Lithography Systems Market Pegged for Robust Expansion During 2021-2031
The COVID-19 crisis has led to a shortage of semiconductor products, owing to a slowdown in production activities. Nevertheless, changing consumer habits are grabbing the attention of companies in the DUV lithography systems market, pertaining to the demand for gaming consoles, TVs, and 5G-enabled smartphones, among others. Get More Report Details- https://www.transparencymarketresearch.com/duv-lithography-systems-market.html On the other hand, the electrification of vehicles is anticipated to generate great future revenue opportunities for manufacturers in the
Electronic Potting & Encapsulating Market To Register Substantial Expansion By 2 …
Potting is the process of filling a complete electronic assembly with a solid or gelatinous compound such as acrylic, silicone, or resins. Potting provides resistance to vibration and shocks. It also offers protection from corrosive agents and moisture. Report Details- https://www.transparencymarketresearch.com/electronic-potting-encapsulating-market.html Encapsulation forms a frame around an object and fills the space between the frame and the object with compounds by using a reusable mold. The key purpose of encapsulation is to

All 5 Releases


More Releases for CIPD

The CIPD accredits a further two Engage in Learning e-learning courses
The only body in the world that’s able to award Chartered status to individual HR and L&D professionals - the CIPD - has accredited a further two e-learning courses from Engage in Learning. Hot on the heels of the CIPD accrediting Engage in Learning’s ‘Unconscious Bias’ and ‘Unconscious Bias for Managers’ courses, confirming that their learning value and structure conforms to continuous professional development (CPD) guidelines, comes news that the CIPD
CIPD accredits Unconscious Bias e-learning courses from Engage in Learning
Two e-learning courses from Engage in Learning covering unconscious bias have been accredited by the CIPD - the only body in the world that can award Chartered status to individual HR and L&D professionals. In officially accrediting the Engage in Learning courses – ‘Unconscious Bias’ and ‘Unconscious Bias for Managers’ – the CIPD confirmed that their learning value and structure conforms to CPD guidelines. Moreover, the courses’ assessor, from the CIPD,
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Growing Research in the Field of CIPD Treatment is Expected to Deliver New Drugs …
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market: Curre …
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow
Chronic Inflammatory Demyelinating Polyneuropathy (CIPD) Treatment Market Resear …
Chronic inflammatory demyelinating polyneuropathy (CIPD) is an autoimmune disorder of the peripheral nervous system characterized by the weakness and impaired sensory function in the arms and legs. This disorder is caused by damage to the myelin sheath, a fatty covering that wraps and protects nerve fibers. The nerves stimulate muscle contraction and transmit sensory information to the brain through electrical impulses. Myelin acts as an insulation and allows efficient flow